Former Novo Nordisk CEO Lars Rebien opened factory in Russia – "I've been too naive"

The war in Ukraine has been a wake-up call for the Danish business sector, which had been blinded by global opportunities, says Lars Rebien Sørensen, chairman of the Novo Nordisk Foundation.

Lars Rebien Sørensen, chair of the board of directors of the Novo Nordisk Foundation | Photo: Stine Bidstrup/ERH

When Lars Rebien Sørensen served as CEO of Novo Nordisk from the year 2000 until the end of 2016, he was responsible for putting the Danish pharmaceutical firm on the map in Russia through large investments into a local factory, which opened in 2015.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs